Quinoxaline 1,4-di-N-Oxide and the Potential for Treating Tuberculosis

E-ISSN： 2212-3989|11|2|196-204

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.11, Iss.2, 2011-04, pp. : 196-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents

By Ortega M.A. Morancho M.J. Martinez-Crespo F.J. Sainz Y. Montoya M.E. Lopez de Cerain A. Monge A.

European Journal of Medicinal Chemistry, Vol. 35, Iss. 1, 2000-01 ,pp. : 21-30

Elsevier

Access to resources Recommend Favorite

Recent Advances in Design of Potential Quinoxaline Anti-Infectives

Current Medicinal Chemistry, Vol. 21, Iss. 38, 2014-12 ,pp. : 4347-4373

Bentham Science Publishers

Access to resources Recommend Favorite

Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity

By Carta A. Paglietti G. Rahbar Nikookar M.E. Sanna P. Sechi L. Zanetti S.

European Journal of Medicinal Chemistry, Vol. 37, Iss. 5, 2002-05 ,pp. : 355-366

Elsevier

Access to resources Recommend Favorite

Quinoxaline 1,4-Dioxide: A Versatile Scaffold Endowed With Manifold Activities

Current Medicinal Chemistry, Vol. 12, Iss. 19, 2005-09 ,pp. : 2259-2272

Bentham Science Publishers

Access to resources Recommend Favorite

Inhaled Dry Powder Formulations for Treating Tuberculosis

Current Drug Delivery, Vol. 12, Iss. 1, 2015-02 ,pp. : 26-39

Bentham Science Publishers

Access to resources Recommend Favorite